Work

Mast cell agonism for glioblastoma immunotherapy

Year: 2026

Type: article

Abstract: Biodegradable polymer scaffold developed to investigate controlled local delivery of a mast cell agonist as an immunotherapy for glioblastoma.

Source: RSC Pharmaceutics

DOI: 10.1039/d6pm00144k

Authors: Sophie E. Mendell, Elizabeth G. Graham-Gurysh, Ryan N. Woodring, Luis Ontiveros-Padilla, Nicole Rose Lukesh, Kevin E. Shilling, Eric M. Bachelder, Kristy M. Ainslie

Institutions: University of North Carolina at Chapel Hill, North Carolina State University

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: Foundation for the National Institutes of Health

Awards: G2820276288, G4801515228, G5285338485, G6341667481, G6407277232, G851999828

OpenAlex ID: W7172054853

FWCI:

Cites: 67

Cited by:

Related to: